1991
DOI: 10.2165/00003088-199121020-00001
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Pharmacokinetics of Drugs Administered Buccally and Sublingually

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

1994
1994
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 67 publications
0
17
0
Order By: Relevance
“…The oral cavity has been used for urgent absorption of drugs and/or for preventing intestinal and hepatic chemical destruction (Motwani and Lipworth, 1991;Squier and Johnson, 1975;Squier and Wertz, 1996), Sublingual drugs should have acceptable taste, reasonable saliva solubility and an absorption ability from mucous membranes (Beckett and Triggs, 1967;Beckett and Moffat, 1971). Nifedipine [1,4-dihydropyridine] is a calcium channel blocking agent that reduces the blood pressure (at doses of 20-30 mg) by vascular smooth muscle relaxation and has negative inotropic and chronotropic effects in the heart .…”
Section: Discussionmentioning
confidence: 99%
“…The oral cavity has been used for urgent absorption of drugs and/or for preventing intestinal and hepatic chemical destruction (Motwani and Lipworth, 1991;Squier and Johnson, 1975;Squier and Wertz, 1996), Sublingual drugs should have acceptable taste, reasonable saliva solubility and an absorption ability from mucous membranes (Beckett and Triggs, 1967;Beckett and Moffat, 1971). Nifedipine [1,4-dihydropyridine] is a calcium channel blocking agent that reduces the blood pressure (at doses of 20-30 mg) by vascular smooth muscle relaxation and has negative inotropic and chronotropic effects in the heart .…”
Section: Discussionmentioning
confidence: 99%
“…Faster absorption and higher maximum concentrations were observed following the bite and swallow method when compared with other methods of dosing (94). Therefore, patients should be instructed to bite the capsule and immediately swallow the contents and the gelatin coating when using nifedipine for the treatment of hypertensive crises (96).…”
Section: Calcium-channel Blockersmentioning
confidence: 99%
“…The oral cavity has been investigated as an alternative route of delivery for therapeutic small molecules and macromolecules having low oral bioavailability due to poor gastrointestinal (GI) absorption, GI instability, and/or susceptibility to first‐pass metabolism 1–3…”
Section: Introductionmentioning
confidence: 99%